Women's Health
Pelvital raises $2.3m to advance commercialisation of Flyte device
US-based women’s health medtech company, Pelvital, has closed an additional $2.32m in seed plus funding to commercialise its Flyte device.…
UK NICE backs use of GENinCode’s test for ovarian cancer surveillance
The UK National Institute for Health and Care Excellence (NICE) has recommended the use of GENinCode’s Risk of Ovarian Cancer…
Cosm Medical wins FDA clearance for personalised Gynethotics pessaries
The US Food and Drug Administration (FDA) has granted clearance to Cosm Medical for its Gynethotics Pessaries for pelvic floor…
Affluent implants artificial sphincter in urinary incontinence study
French company Affluent Medical has completed the first successful implantation of its Artus device for the treatment of urinary incontinence.…
Womed’s intrauterine adhesion device found effective in study
France-based FemTech company Womed has announced positive results from a clinical trial of its Womed Leaf device, deeming it effective…
Roche wins CE mark for PCOS diagnostic immunoassay
Roche Diagnostics has received a CE mark for Elecsys anti-müllerian hormone (AMH) plus immunoassay as a diagnostic blood test for…
US researchers develop method for preterm birth risk prediction
Researchers from the University of Illinois Chicago (UIC) and University of Illinois Urbana-Champaign (UIUC) in the US have developed an…
Femasys opens another site in trial for permanent birth control device
Femasys’ pivotal FINALE trial for its permanent birth control device is well under way, and the women’s health company has…
Femasys starts birth control solution trial at Stanford Medicine
Femasys has initiated the enrolment of subjects at Stanford Medicine in Palo Alto, California, US, for FemBloc, a non-implant, non-surgical…
Experts say femtech funding booming despite wider investment downturn
The femtech sector is going from strength to strength, despite the weaker investment landscape throughout the healthcare industry, experts say.…
